The US Justice Department has issued an order moving medical marijuana to Schedule III, removing some barriers to access for patients and researchers.

Tempero Bio, a drug developer that had big ambitions to shake up the treatment of substance use disorders, is winding down operations, Endpoints News has

MAHA’s sway over HHS could face a fresh test now that President Trump has a new pick for CDC director: Erica Schwartz, a former deputy

The radioligand field is on the cusp of a major competitive moment, as a rival looks to bring the first generic to a market that’s

This week’s crop of private financings includes nine-figure rounds for Ray Therapeutics and Tortugas, with Serif and Alloy also in on the action.